Skip to main content
U.S Department of Health and Human Services (HHS) National Institutes of Health
Español
HomeFind Clinical TrialsRemote Assessment of Early-Stage Dementia Care Needs
Find more clinical trials

Remote Assessment of Early-Stage Dementia Care Needs

Start: April 27, 2021
End: June 25, 2022
Enrollment: 48

What Is This Study About?

This study will inform and test the development of READyR, a program to help people with mild cognitive impairment or early-stage dementia and their primary family care partner (i.e., partner or spouse) identify unmet dementia-care needs. Researchers will use in-home sensors and wearable technology to collect digital information about behavior patterns over six weeks. This data will be combined with information from each participant pair about their care values and priorities to customize their READyR assessments. Participants will be randomly assigned to either begin the program immediately or be put on a waitlist to begin the program at a later time. The first group will receive the remote monitoring technology and attend three program assessment sessions. During their waitlist period, the second group will receive a one-hour support session about dementia-related care needs followed by a check-in call three weeks later and a follow-up assessment. Over three months, researchers will evaluate changes in the participant's level of future preparation, relationship quality, care-related strain, and quality of life.

Do I Qualify To Participate in This Study?

Minimum Age: 62 Years

Maximum Age: N/A

Must have:

Persons With Dementia:

  • Probable or confirmed diagnosis of mild cognitive impairment or early-stage dementia
  • Montreal Cognitive Assessment test score > 15 
  • Speak and read English

Family Care Partners Inclusion:

  • 21 years or older
  • Self-identifying as a family member and care partner living in the same home as the person with dementia
  • Speak and read English

Must NOT have:

  • Any condition that would limit study participation (e.g., uncorrected vision or hearing impairments)
  • Any uncontrolled medical condition that could prevent study completion (e.g., late-stage cancer)

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Oregon Health and Science University

Collaborator Sponsor

  • National Institute on Aging (NIA)

Source: ClinicalTrials.gov ID: NCT04542109